Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea

NCT00864812 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

509

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: tiotropium with fluticasone propionate/salmeterol (FSC)
DRUG: tiotropium

Sponsor

The Korean Academy of Tuberculosis and Respiratory Diseases

Collaborators

[object Object]